Previous 10 |
home / stock / mmedf / mmedf news
NEW YORK , Aug. 14, 2020 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), the leading psychedelic pharmaceutical company, has announced its second quarter financial results for the three and six months ended June 30 , 2020. Complete financial st...
BASEL, Switzerland , Aug. 13, 2020 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF) is expanding its presence in Europe . The leading neuro-pharmaceutical company for psychedelic inspired medicines will open an operating subsidiary in Switzerland that will ove...
The psychedelics boom is alive and well thanks in part to a landmark decision on psilocybin mushrooms. Just days ago, the Canadian government allowed four terminally ill patients with cancer to receive psilocybin therapy to help ease end-of-life distress. This is the first time in 46 years th...
Venture Company Investor Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, Aug. 10, 2020 Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , Aug....
MindMed Adds Psychedelic Assisted Therapy Expert Dr. Peter Gasser As Clinical Advisor For Project Lucy Canada NewsWire NEW YORK, Aug. 6, 2020 Applauds Health Canada's Approval Of Psilocybin Compassionate Access For Patients NEW YORK , Aug. 6, 2020 /CNW/ -- Mind M...
Live Investor Conference & Webinar: Venture Companies Present August 6th Live Investor Conference & Webinar: Venture Companies Present August 6th Canada NewsWire NEW YORK, Aug. 3, 2020 Company executives will share vision and answer audience questions at VirtualIn...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 9, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC:MMEDF)(DE: BGHM) (the “Company”), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic inspired medicines, announces that J.R. Rahn, the Com...
Last week, Deepak Chopra revealed that he’d entered into a new partnership with MindMed (NEO: MMED) (OTCQB: MMEDF), which aligned with his continued interest in mind-body healing. MindMed is a clinical-stage biotech company that is researching psychedelic medicine. In his stat...